phenindione has been researched along with Carcinoma, Transitional Cell in 1 studies
Phenindione: An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SORG, DA | 1 |
| HINES, JJ | 1 |
| KESSLER, DL | 1 |
1 other study available for phenindione and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
HYPOPROTHROMBINEMIA AND UNSUSPECTED MALIGNANCY.
Topics: Adenocarcinoma; Anticoagulants; Carcinoma; Carcinoma, Transitional Cell; Coronary Disease; Diabetes | 1964 |